HENRY BARRAZA: Open Payments
NPI 1417043340 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 9 payments from 6 companies in 2025. Trend: 2023 $137 · 2024 $145 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $170 |
| Novo Nordisk Inc | 2 | $136 |
| SANOFI PASTEUR INC. | 1 | $28 |
| ABBVIE INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: MOUNJARO, Wegovy, BEYFORTUS, UBRELVY, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across CA — which companies pay providers there.
